Coherus Oncology (CHRS) Acquisitions (2014)
Coherus Oncology (CHRS) reported Acquisitions of $7 million for FY2023.
Powered by 
Analysis
Coherus Oncology (CHRS) Acquisitions (2014) Analysis & Trends
- Acquisitions has a five-year compound annual growth rate of 87.7% (FY2018 to FY2023).
- The FY2023 figure ranks as the lowest annual Acquisitions since FY2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.75 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | -17.24 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 23.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 11.21 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | - |
API Access
Coherus Oncology Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();